Obesity and Bone Loss at Menopause: The Role of Sclerostin.

Diagnostics (Basel) · 2021 · PMC8534901 · PMID 34679612

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Analysis of bone-related parameters only revealed between-group differences in CTX and NTX levels while sclerostin levels showed a trend toward an increase after menopause ( Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.